申请人:Kishino Hiroyuki
公开号:US20080200494A1
公开(公告)日:2008-08-21
The invention provides imidazopyridine derivatives represented by the general formula [I] [in which R
1
and R
2
may be the same or different and stand for C
1-6
alkyl or the like, R
3
and R
4
stand for hydrogen atom, methyl group or the like, W stands for mono- or bi-cyclic 3- to 8-membered aromatic or aliphatic heterocycle or the like, and Ar stands for optionally substituted aromatic heterocycle or the like]. These compounds act as melanin-concentrating hormone receptor antagonist and are useful as medicines for central nervous system disorders, cardiovascular system disorders and metabolic disorders.
该发明提供了由通式[I]表示的咪唑吡啶衍生物 [其中R1和R2可能相同或不同,且代表C1-6烷基或类似物,R3和R4代表氢原子,甲基基团或类似物,W代表单环或双环的3-8元芳香或脂肪杂环或类似物,Ar代表可选择取代的芳香杂环或类似物]。这些化合物作为黑色素浓集激素受体拮抗剂,可用于治疗中枢神经系统疾病、心血管系统疾病和代谢性疾病的药物。